Death receptor 5-recruited raft components contributes to the sensitivity of Jurkat leukemia cell lines to TRAIL-induced cell death

IUBMB Life

Volumn 61, Issue 3, 2009, Pages 261-267

  Min, Yifan ^a   Shi, Juan ^a   Zhang, Yaxi ^a   Liu, Shilian ^a   Liu, Yanxin ^a   Zheng, Dexian ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Acid sphingomyelinase; DR5; Jurkat leukemia cell lines; Lipid raft; TRAIL

Indexed keywords

CASPASE 8; DEATH RECEPTOR 5; FAS ASSOCIATED DEATH DOMAIN PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROCASPASE 8; PROTEIN P85; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ARTICLE; CELL DEATH; CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PROTEIN EXPRESSION;

EID: 77951073166     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.166     Document Type: Article

References (43)

1. Shi, J., Zheng, D., Man, K., Fan, S. T., and Xu, R. (2003) TRAIL: a potential agent for cancer therapy. Curr. Mol. Med. 3, 727-736.
2. Kruyt, F. A. (2008) TRAIL and cancer therapy. Cancer. Lett. 263, 14-25.
3. Baritaki, S., Suzuki, E., Spandidos, D. A., Berenson, J., Daniels, T. R., Penichet, M. L., Jazirehi, A. R., Palladino, M., and Bonavida, B. (2008) Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cells. J. Immunol. 180, 6199-6210.
4. Kim, S. H., Ricci, M. S., and El-Deiry, W. S. (2008) Mcl-1: a gateway to TRAIL sensitization. Cancer Res. 68, 2062-2064.
5. Perez, L. E., Parquet, N., Shain, K., Nimmanapalli, R., Alsina, M., Anasetti, C., and Dalton, W. (2008) Bone marrow stroma confers resistance to Apo2 ligand/TRAIL in multiple myeloma in part by regulating c-FLIP. J. Immunol. 180, 1545-1555.
6. Felber, M., Sonnemann, J., and Beck, J. F. (2007) Inhibition of novel protein kinase C-epsilon augments TRAIL-induced cell death in A549 lung cancer cells. Pathol. Oncol. Res. 13, 295-301.
7. Zhang, J., Liu, N., Zhang, J., Liu, S., Liu, Y., and Zheng, D. (2005) PKCd protects human breast tumor MCF-7 cells against tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis. J. Cell. Biochem. 96, 522-532.
8. Liu, Y., Hu, H., and Zheng, D. (2002) Profile of gene expression in rsTRAIL-induced cancer cell death. Acta CAMS 24, 238-241.
9. Liu, N., Zhang, J., Zhang, J., Liu, S., Liu, Y., and Zheng, D. (2008) Erbin regulated sensitivity of MCF-7 breast cancer cells to TRAIL via ErbB2/AKT/NF-{kappa}B pathway. J. Biochem. 143, 793-801. (Pubitemid 351918941)
10. Sheridan, J. P., Marsters, S. A., Pitti, R. M., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C. L., Baker, K., Wood, W. L., Goddard, A. D., Godowski, P., and Ashkenazi, A. (1997) Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277, 818-821.
11. Walczak, H., Degli-Esipsti, M. A., Johnson, R. H., Smolak, P. G., Waugh, G. Y., Bioani, N., Timour, M. S., Gerhart, M. J., Schooley, K. A., Smith, C. A., Goodwin, R. G., and Rauch, C. T. (1997) TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 16, 5386-5397.
12. Pan, G., Ni, J., Wei, Y. F., Yu, G., Gentz, R., and Dixit, V. M. (1997) An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277, 815-818. (Pubitemid 27366732)
13. Degli-Esposti, M. A., Smolak, P. J., Walczak H., Waugh, G., Huang, C. P., DuBose, R. F., Goodwin, R. G., and Smith, C. A. (1997) Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J. Exp. Med. 186, 1165-1170.
14. Degli-Esposti, M. A., Dougall, W. C., Smolak, P. J., Waugh, G. Y., Smith, C. A., and Goodwin, R. G. (1997) The novel receptor TRAIL-R4 induces NF-kappaB and protests agaist TRAIL-mediated apoptosis, yet a retains an incomplete death domain. Immunity 7, 813-820.
15. Emery, J. G., McDonnell, P., Burck, M. B., Deen, K. C., Lyn, S., Silverman, C., Due, E., Applebaun, E. R., Eichmen, C., Diprinzio, R., Dodds, R. A., James, I. E., Rosenberg, M., Lee, J. C., and Young, P. R. (1998) Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J. Biol. Chem. 273, 14363-14367.
16. Boldin, M. P., Varfolomeev, E. E., Pancer, Z., Mett, I. L., Camonis, J. H., and Wallach, D. (1995) A novel protein that interacts with the death domain of Fas/APO-1 contains a sequence motif related to the death domain. J. Biol. Chem. 270, 7795-7798.
17. Hsu, H., Shu, H. B., Pan, M. G., and Goeddel, D. V. (1996) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308. (Pubitemid 26042835)
18. Hsu, H., Huang, J., Shu, H. B., Baichwal, V., and Goeddel, D. V. (1996) TNF-dependent recruitment of the protein kinase RIP to the TNF-receptor-1 signaling complex. Immunity 4, 387-396. (Pubitemid 26174054)
19. Sprick, M. R., Weigand, M. A., Rieser, E., Rauch, C. T., Juo, P., Blenis, J., Krammer, P. H., and Warczak, H. (2000) FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12, 599-609.
20. Kischkel, F. C., Lawrence, D. A., Chuntharapai, A., Schow, P., Kim, K. J., and Ashkenazi, A. (2000) Apo2L/TRAIL -dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12, 611-620.
21. Sprock, M. R., Rieser, E., Stahl, H.,Grosse- Wilde, A., Weigand, M. A., and Walczak, H. (2002) Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but functionally substitute caspase-8. EMBO J. 21, 4520-4530. (Pubitemid 34984339)
22. Gajate, C. and Mollinedo, F. (2007) Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and down stream signaling molecules into lipid rafts. Blood 109, 711-719. (Pubitemid 46105973)
23. Simons, K. and Ikonen, E. (1997) Functional rafts in cell membranes. Nature 387, 569-572.
24. Scheel-Toellner, D., Wang, K., Singh, R., Majeed, S., Raza, K., Curnow, S. J., Salmon, M., and Lord, J. M. (2002) The death-inducing signalling complex is recruited to lipid rafts in Fas-induced apoptosis. Biochem. Biophis. Res. Commun. 297, 876-879.
25. Lacour, S., Hammann, A., Grazide, S.,Lagadic- Gossmann, D., Athias, A., Sergent, O., Laurent, G., Gambert, P., Solary, E., and Dimanche- Boitrel, M. T. (2004) Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. Cancer Res. 64, 3593-3598.
26. Nieto-Miguel, T., Gajate, C., and Mollinedo, F. (2006) Differential targets and subcellular location of antitumor alkyl-lysophospholipid in leukemic versus solid tumor cells. J. Biol. Chem. 281, 14833-14840.
27. Shi, J., Zhang, J., Chang, X., Liu, S., Liu, Y., and Zheng, D. (2003) Expression and biological activity of the soluble recombinant tumor necrosis factor related apoptosis inducing ligand. China Biotechnol. 23, 46-49.
28. Shi, J., Zheng D., Liu, Y., Sham, M. H., Tam, P., Farzaneh, F., and Xu, R. (2005) Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice. Cancer Res. 65, 1687-1692. (Pubitemid 40478593)
29. Gajate, C. and Mollinedo, F. (2001) The antitumor ether lipid ET-18-OCH3 induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells. Blood 98, 3860-3863.
30. Erdreich-Epstein, A., Tran, L. B., Cox, O. T., Huang, E. Y., Laug, W. E., Shimada, H., and Millard, M. (2005) Endothelial apoptosis induced by inhibition of integrins αvβ3 and αvβ5 involves ceramide metabolic pathways. Blood 105, 4353-4361. (Pubitemid 40720781)
31. Sheng, H., Shao, J., Townsend, C. M. Jr., and Evers, B. M. (2003) Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells. Gut 52, 1472-1478. (Pubitemid 37176728)
32. Gulbins, E. and Kolesnick, R. (2003) Raft ceramide in molecular medicine. Oncogene 22, 7070-7077.
33. Elyassaki, W. and Wu, S. (2006) Lipid rafts mediate ultraviolet light-induced Fas aggregation in M624 melanoma cells. Photochem. Photobiol. 82, 787-792.
34. Keane, M. M., Ettenberg, S. A., Nau, M. M., Russell, E. K., and Lipowitz, S. (1999) Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer. Res. 59, 734-751.
35. Nam, S. Y., Amoscato, A. A., and Lee, Y. J. (2002) Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide-Akt-FLIP pathway. Oncogene. 17, 337-346.
36. Chen, Q., Gong, B.,Mahmoud- Ahmed, A. S., Zhou, A., His, E. D., Hussein, M., and Alamsan, A. (2001) Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma. Blood 98, 2183-2192.
37. Farrow, B., Thomas, R. P., Wang, X. F., and Evers, B. M. (2002) Activation of conventional PKC isoforms increases expression of the pro-apoptotic protein Bad and TRAIL receptors. Int. J. Gastrointest. Cancer 32, 63-72
38. Sheikh, M. S. and Huang, Y. (2004) TRAIL death receptors, Bcl-2 protein family, and endoplasmic reticulum calcium pool. Vitam. Horm. 67, 169-188.
39. Jones, S. M., Alb, J. G., Phillips, S. E., Bankaitis, V. A., and Howell, K. E. (1998) A phosphatidylinositol 3-kinase and phosphatidylinositol transfer protein act synergistically in formation of constitutive transport vesicles from the trans-golgi network. J. Biol. Chem. 273, 10349-10354.
40. Davidson, H. W. (1995) Wortmannin causes mistargeting of procathepsin D. Evidence for the involvement of a phosphatidylinositol 3-kinase in vesicular transport to lysosomes. J. Cell. Biol. 130, 797-805.
41. Pettus, B. J., Chalfant, C. E., and Hannun, Y. A. (2002) Ceramide in apoptosis: an overview and current perspectives. Biochim. Biophys. Acta 1585, 114-125. (review).
42. Beaujouin, M. and Liaudet- Coopman, E. (2008) Cathepsin D overexpressed by cancer cells can enhance apoptosis-dependant chemo-sensitivity independently of its catalytic activity. Adv. Exp. Med. Biol. 617, 453-461.
43. Lee, Y. J. and Amoscato, A. A. (2004) TRAIL and ceramide. Vitam. Horm. 67, 229-255.